ams Agrees to Divest NFC and RFID Reader Wireless Product Lines to STMicroelectronics

ams, a leading worldwide manufacturer of high performance sensor and analog solutions, has signed an agreement to divest NFC and RFID reader IP, technologies and product lines to STMicroelectronics (NYSE: STM) for an up-front cash consideration of USD 79.3m (approx. EUR 71.5m) plus a substantial deferred earn-out consideration contingent on future results of up to USD 37 million.

With this transaction, ams takes another significant step on its path to being the leading provider of sensor solutions worldwide. ams will retain its sensor-related NFC/RFID tags business and relevant design capabilities to create wireless IoT sensor solutions and support upcoming sensor nodes.

The transaction is part of ams’ ongoing efforts to actively manage its portfolio of technologies with a clear focus on implementing its sensor solutions strategy. The divestment comprises ams’ NFC assets, including NFC front-end and antenna boost solutions, and integrated HF/UHF RFID reader assets. The related design and marketing resources are mostly based in Premstaetten, Austria, and Ljubljana, Slovenia, and include around 50 employees which will be transferred to STMicroelectronics. ams will retain its NFC/RFID wireless tags business and related IP and plans to create wireless sensor solutions for IoT applications combining NFC and RFID connectivity interfaces with its portfolio of sensors.

The transaction is expected to close today as no regulatory approvals are needed. ams expects to deconsolidate the business lines covered by the transaction from 1 August 2016 onwards.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.